Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion type Assertion NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_head.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_provenance.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion evidence source_evidence_literature NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_provenance.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion SIO_000772 21712540 NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_provenance.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion wasDerivedFrom befree-20150227 NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_provenance.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion wasGeneratedBy ECO_0000203 NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_provenance.